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A diet enriched with red sorghum flaked biscuits, compared to a diet containing 
white wheat flaked biscuits, does not enhance the effectiveness of an energy-
restricted meal plan in overweight and mildly obese adults 
Abstract 
Objectives: Whole grain sorghum is a promising ingredient in foods, especially those targeting satiety and 
weight control. This study aimed to test weight loss effects of a whole grain red sorghum product 
incorporated into an energy-restricted diet. 
Methods: Sixty subjects (46 females) were randomized to either a sorghum (intervention) or white wheat 
(control) group, receiving 45 g of flaked cereal biscuits to include daily in their prescribed diets for 12 
weeks. Primary outcome was weight loss. Secondary outcomes included plasma glucose, glycosylated 
hemoglobin (HbA1c), insulin, total cholesterol, high-density lipoprotein cholesterol (HDL-c), low-density 
lipoprotein cholesterol (LDL-c), triacylglycerides (TAG), interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor 
alpha (TNF-α), high-sensitivity C-reactive protein (hs-CRP), and total antioxidant capacity (TAC; measured 
at 0 and 12 weeks). 
Results: After 12 weeks, there were no significant differences in weight loss or any clinical variables 
between a wheat control and sorghum cereal group in an energy-restricted diet. Equivalent amounts of 
weight were lost (p = 0.369) in both groups, and the majority of clinical indices such as fasting glucose, 
insulin, cholesterol, and key inflammatory biomarkers showed significant beneficial changes over time (p 
< 0.05). 
Conclusions: Although both groups experienced significant weight loss and general improvement in a 
number of clinical measures, no effects appeared specifically related to sorghum consumption. Further 
clinical trials are necessary to establish an evidence base for weight loss effects from chronic sorghum 
intake. Sorghum represents a viable, gluten-free grain alternative in the formulation of novel food 
products. 
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ABSTRACT 
Objectives: Whole grain sorghum is a promising ingredient in foods, 
especially those targeting satiety and weight control. This study aimed to test weight 
loss effects of a whole grain red sorghum product incorporated into an energy-
restricted diet.   
Methods: Sixty subjects (46 females) were randomized to either a sorghum 
(intervention) or white wheat (control) group, receiving 45g of flaked cereal biscuits 
to include daily in their prescribed diets for 12 weeks. Primary outcome was weight-
loss. Secondary outcomes included plasma glucose, HbA1c, insulin, total cholesterol, 
HDL-C, LDL-C, TAG, IL1β, IL-6, IL-8, TNFα, hsCRP, TAC (measured at 0 and 12 
weeks).  
Results: After 12 weeks, there were no significant differences in weight loss 
or any clinical variables between a wheat control and sorghum cereal group in an 
energy-restricted diet.  Equivalent amounts of weight were lost (p=0·369) in both 
groups and the majority of clinical indices such as fasting glucose, insulin, cholesterol 
and key inflammatory biomarkers showed significant beneficial changes over time 
(p<0.05).  
Conclusions: Although both groups experienced significant weight loss and 
general improvement in a number of clinical measures, no effects appeared 
specifically related to sorghum consumption. Further clinical trials are necessary to 
establish an evidence base for weight loss effects from chronic sorghum intake. 
Sorghum represents a viable, gluten-free grain alternative in the formulation of novel 
food products.  
  
   
INTRODUCTION  
Dietary patterns rich in plant foods are positively associated with indicators of health [1]. 
These diets include a variety of foods and food components that have beneficial effects on 
disease markers and health outcomes, including body weight regulation, important in the 
prevention of chronic disease [2]. Characteristically high in dietary fiber, phytonutrients and 
lower in total energy value, the purported benefits of these diets may be attributed to 
mechanisms involving satiety and appetite regulation, glycemic and insulinemic control, lipid 
regulation, and reduced oxidative stress and inflammatory processes.  
 
Whole grain cereal foods constitute an important component of plant-based diets. They are a 
source of dietary fiber and contain an array of bioactive compounds, including polyphenols. 
Sorghum (Sorghum bicolor L. Moench) is an example of a gluten-free whole grain cereal, 
with a reputation for being satiating [3]. Not surprisingly, sorghum is gaining attention from 
food manufacturers and researchers as a suitable ingredient in foods targeting satiety to assist 
with longer-term weight management, particularly in populations where obesity-related 
diseases are prevalent and food is ubiquitous [4]. Sorghum’s appeal is further enhanced by its 
potential as a sustainable crop with numerous agronomic advantages including low 
production costs, high temperature tolerance and adaptability to drought [5, 6]. 
 
Sorghum grain is mostly composed of starch, with levels reported as high as 71% of dry 
whole grain weight in some cultivars [7]. Sorghum starch granules are entangled in a strong 
protein matrix in the corneous endosperm (hard outer region) of the grain kernel, which may 
impede the actions of carbohydrate-hydrolyzing enzymes, resulting in reduced in vitro starch 
digestibility [8]. The starch granules exist in a more open structure in the floury endosperm of 
the grain kernel. More commonly utilized hard wheat is also characterized by a higher ratio of 
  
   
corneous to floury endosperm, in which the starch granules are more tightly bound to proteins. 
The lower starch digestibility may also be a consequence of interactions with the cell wall 
material and polyphenolic compounds such as flavonoids (namely anthocyanins) and 
condensed tannins [9, 10]. A variety of sorghum-based foods have been confirmed to deliver 
slowly digestible starches (SDS) [11, 12], which have been associated with lower glucose 
responses, and in some cases lower glycemic index (GI) [13]. Together with dietary and 
resistant starch, this array of qualities may result in enhanced satiety through which sorghum 
grain components may play a role in longer-term weight management and protection against 
obesity-related chronic diseases [5]. To date, indications for such effects have predominantly 
come from in-vitro [11,13] and animal studies [14, 15]. Our group has previously conducted 
the only clinical trial investigating satiety mechanisms relating to sorghum grain 
consumption in humans [16]. Using a crossover design in 20 male and 20 females subjects, 
three different types of sorghum flaked whole grain cereal biscuits (made from red, white or 
brown grained sorghum varieties and differing in polyphenolic content) were shown to 
extend acute subjective satiety sensations and increase satiety-enhancing gut hormones 
(GLP-1 and GIP and PYY in males) to a greater extent than a wheat control over a 4-hour 
period (p<0.05), although food intake at a second meal was not altered. The flaked biscuits 
made from red sorghum grain, a variety rich in anthocyanin flavonoids, elicited the greatest 
overall satiety-enhancing responses. We were unable to explain the responses in terms of the 
dietary fiber or the starch contents of the biscuits, but overall differences in polyphenol 
contents may have assisted the satiety responses.  
 
While these initial acute satiety results were promising, longer-term effects on body weight 
and chronic disease biomarkers are the main target for providing evidence of health benefits. 
The present paper describes a 3-month randomized controlled dietary intervention trial, 
  
   
designed to test effects of whole grain red sorghum included in an energy-restricted meal 
plan. The primary outcome was weight loss. Secondary outcomes were biochemical measures 
linked with change in body weight, such as glucose, insulin, cholesterol and a number of anti-
inflammatory/oxidative stress markers, as well as subjective satiety measures. We 
hypothesized that (1) subjects receiving foods made from whole grain sorghum would lose 
more weight than subjects receiving control foods (wheat-based); (2) weight loss would be 
accompanied by changes in metabolic disease risk factors, which may be anticipated given the 
high polyphenolic content of the sorghum. 
 
METHODS AND MATERIALS 
Subjects and recruitment 
This study was a 3-month, double-blinded, parallel, randomized controlled trial with a total of 
60 subjects, 46 females and 14 males. There were two arms to the study: sorghum 
intervention and wheat control, with both groups receiving advice on an energy-restricted diet 
from an Accredited Practising Dietitian. All subjects were provided with cereal products, in 
the form of flaked breakfast biscuits, to include in their diets. The target sample size of 30 
subjects per group was based on previous human intervention studies incorporating 
cereal/high fiber foods into hypo-caloric diets [17-19]. Difference in weight loss between 
groups was used as the primary outcome measure to establish power for the study. To observe 
a two-kilogram weight difference between groups, at a power of 80% and to be significantly 
different at level of α 0.05, 26 subjects would be required per group. Therefore, setting the 
recruitment target at 30 subjects per group would account for an approximate dropout rate of 
15%. Eligible subjects (aged 18–65 years, BMI range from 25–35 kg/m
2
) were sought 
through paid media advertisements and institutional emails. Subjects with serious illness 
including diabetes, with known food allergies, and those taking appetite-altering medications 
  
   
were excluded from the study. Restrictive eaters (identified using the Three Factor Eating 
Questionnaire by Stunkard & Messick [20]) and subjects who were smokers, were pregnant, 
breastfeeding and post-menopausal were also excluded. All procedures were approved by the 
University of Wollongong, Human Research Ethics Committee (approval number HE14/100). 
The trial was also prospectively registered with the Australian New Zealand Clinical Trials 
Registry (ACTRN12614000640606).  
 
A total of 115 potential subjects expressed interest in the study of which 103 were contacted 
to undergo further preliminary screening via telephone (Figure 1). From this group, 80 people 
were eligible for further assessment in the form of a detailed screening questionnaire. This led 
to sixty-one people attending an interview to determine final eligibility with sixty subjects 
randomized into the two study groups by a researcher independent of the subject interface, 
stratified by sex, block randomized using STATA Version 12 and using the RALLOC 
command (StataCorp, 2011, College Station, Texas, USA). The researcher/dietitian and all 
subjects at the subject interface were blinded to the randomization. The subjects attended the 
clinical research trials unit (CRTU) at the University of Wollongong, Australia, on five 
occasions. The first visit included collection of background dietary data using a validated diet 
history interview [21] and instruction on the completion of a 3-day weighed food record. The 
subsequent visit included collection of fasting blood samples (baseline) and dietary education. 
Two follow-up dietary visits occurred at the 1-month and 2-month time-points, with 
collection of fasting blood samples at 3 months (final visit). All the subjects had their height, 
weight, percentage body fat (Tanita Scales Model no.TBF-662) and waist circumference 
recorded at each visit to the CRTU. Visual analogue scales (VAS) related to appetite [22] and 
food records were all completed at baseline, half-way through the study (at the 6-week point) 
and within the final week of the study. The Baecke Physical Activity Questionnaire [23] was 
  
   
completed at baseline and at the completion of the study. 
 
For the appetite VAS, the subjects recorded their appetite responses on individual forms at six 
different time- points throughout the day: immediately before each of the three main meals 
and 2 h after each of these meals but before their subsequent snack. The VAS consisted of a 
100 mm horizontal line, anchored at each end with opposing responses (for example, "not at 
all hungry" and "never been more hungry"). The study participants were instructed to place a 
vertical mark on the line to correspond with their feelings and the subjective sensation was 
quantified by measuring the distance in millimeters from the left end of the line to the mark. 
All nutritional analysis was performed using FoodWorks 2007, version 5 (Xyris Software, 
Brisbane, QLD, Australia) with nutrient contents of study foods added as required.  
 
Dietary intervention 
For each subject, a basal metabolic energy requirement was calculated using the Mifflin-St 
Jeor equation where a BMI equal to 25 kg/m
2
 was included [24]. A low activity factor (1.3) 
was chosen to estimate energy requirements (given the overweight sample with limited usual 
physical activity) and then this level was reduced by 20% to drive weight loss. Intervention 
diets were designed to control for all macronutrients with the only variation being the trial 
cereal products given, as described in Table 1. The sorghum intervention group received 
whole grain sorghum-based cereal biscuits and the whole wheat control group received 
wheat-based cereal biscuits, matched by serve size (3 biscuits) and therefore overall mass 
(45g per day). Wheat was chosen as the suitable food control because it has a different 
polyphenolic profile to red sorghum but has similar nutritional attributes and, from a 
behavioral perspective, wheat cereal products are readily interchangeable with sorghum 
breakfast cereal products. 
  
   
 
Test food products 
Organoleptically-acceptable test foods were manufactured in the form of ready-to-eat (RTE) 
flaked cereal biscuits, in a pilot processing plant by qualified cereal food technologists, as 
previously described by Stefoska-Needham et al. (2016). The sorghum flaked cereal biscuits 
were processed from red sorghum grain, variety Alpha, grown and supplied by Lochabar 
Enterprises Pty Ltd (Tara, QLD, Australia), with a small amount of added malt extract. A 
bleach test [25] confirmed the absence of tannins in the red sorghum grain. The wheat flaked 
cereal biscuits were made from non-cultivar-specific Australian Prime White (APW) hard 
wheat (grown in central New South Wales, Australia) and was supplied by Sanitarium Health 
and Wellbeing (Cooranbong, NSW, Australia). The whole wheat and whole sorghum grains 
were steamed and then passed between parallel smooth rollers producing whole grain flakes, 
reducing their thickness to 0.1 mm. The flakes were pressed together to form rectangular 
prism-shaped biscuits, which were subsequently toasted in an oven to reduce the moisture 
content and produce a shelf stable product [16]. This process differs from the shredded wheat 
process in that the wheat is not cut into strips at any stage.  
 
The subjects were instructed to eat two cereal biscuits (30g) at breakfast and one biscuit (15g) 
at afternoon tea daily. The proximate, dietary fiber and energy content (on as is basis per 
100g) (Table 2), polyphenolic (PP) content (mg GAE/g as is) (Table 3) and starch properties 
(per 100g as is) (Table 4) were previously reported by Stefoska-Needham et al., 2016). 
Analyses identified modest differences between the control and sorghum biscuits with respect 
to energy, macronutrients and dietary fiber (Table 2). Notably, both total and soluble fiber 
levels were higher in the whole wheat control compared to the sorghum biscuits, however the 
actual difference between biscuits was modest at 0.86g and 0.13g per 45g test serve, 
  
   
respectively. Individual macronutrient levels were not controlled for because this study was 
designed to test whole foods as consumed in real-life settings, hence the serve size rather than 
specific components were matched. As expected, red sorghum biscuits had higher PP levels 
compared to the control (Table 3), most likely due to high anthocyanin contents characteristic 
of this sorghum variety [3]. Assessment of starch properties showed no difference in the 
amount of total starch, rapidly digestible starch (RDS) and slowly SDS between biscuits, and 
in particular the levels of SDS in each serve classified as high (Table 4). 
 
Clinical indices 
Fasting blood samples were collected at 0 and 3 months into clot gel tubes, centrifuged and 
stored at -80° Celsius until analysis could be completed according to standard protocols for 
glucose, insulin, total cholesterol, high-density lipoprotein (HDL-c), low-density lipoprotein 
(LDL-c), triacylglycerides (TAG) and high-sensitivity c-reactive peptide (hsCRP) at Sydney 
Adventist Hospital Pathology (Wahroonga, NSW, Australia). Glycosylated hemoglobin 
(HbA1c) was performed by Southern Pathology (Wollongong, NSW, Australia) after samples 
were collected into tubes containing potassium EDTA and stored at 4° Celsius until analysis 
was conducted. Additional markers for inflammation and oxidative stress, Interleukin 1 
(IL1), Interleukin 6 (IL-6), Interleukin 8 (IL-8), tumor necrosis factor alpha (TNFα) and 
total antioxidant capacity (TAC) were performed by the Australasian Research Institute, 
(Sydney Adventist Hospital, Wahroonga, NSW, Australia) according to established protocols. 
 
Statistical analysis 
Data for all anthropometry, blood analysis, VAS measurements and dietary intake were 
entered into SPSS for windows, version 21.0 (IBM SPSS 21.0, IBM Corporation, Armonk, 
NY, USA). Repeated measures ANOVA (RMANOVA) using the general linear model with 
  
   
group (control, sorghum) as the between subjects factor, was used to identify primary changes 
in each parameter over time and also differences between the groups. Post hoc analysis using 
Bonferroni adjustments was reviewed to detect specific differences between the control and 
intervention groups. Regression analysis was used to identify correlations between group 
anthropometric and biochemical indices.  
 
RESULTS 
Baseline data 
There were twenty-six subjects in the sorghum intervention group (after four subjects 
withdrew) and thirty subjects in the control group (Figure 1). Reasons provided for their 
withdrawal were: relocation, commencement of a contraindicated medication and the lack of 
motivation to adhere to an energy-restricted meal plan. For the final analysis, fifty-six 
subjects were included, although numbers in each calculation varied because some subjects 
did not complete all forms (food records or VAS). There were no significant differences 
between group anthropometric, dietary and metabolic measures at baseline (Table 5), except 
for a slightly lower protein intake in the sorghum group. Baseline energy intakes seemed low, 
suggesting under-reporting by some subjects. Consequently at subsequent study visits, 
dietitians specifically addressed potential under-reporting with subjects when reviewing their 
individual food records. The subjects were mildly obese but overall they did not exhibit 
impaired glucose tolerance or insulin resistance [26], nor were they hyperlipidemic [27] or 
hypertensive [28].  
 
Dietary intervention 
The flaked cereal biscuits were consumed by subjects with no adverse reactions and dietary 
compliance was relatively high at approximately 85%, as determined by a manual count of 
  
   
uneaten biscuits upon study completion. Food record analysis indicated no significant 
difference between the groups for protein, carbohydrate and fat intakes at any of the time-
points once the study commenced. Review of the overall dietary composition of baseline diets 
compared with the 3-month end-point showed a significant decrease in percentage energy 
from fat (p<0.001), as well as saturated fat (p<0.001). Percentage energy from protein and 
carbohydrate was not altered over time (Table 6).  
 
Compliance with a weight reduction meal plan was identified by overall weight loss and 
energy reduction reported in the food records. Total energy intake was significantly lower at 
the mid-point (mean 7136 (SD 2164) kJ) and the end-point (mean 6880 (SD 1815) kJ) 
(p<0.001) of the trial compared with the baseline (mean 8742 (SD 2656) kJ), using 
RMANOVA with treatment as the between-group effect and time as the within-subject 
variant. The lack of an interaction effect over time (p=0.671) suggests that there were no 
differences between groups in energy intake over time. There were no significant differences 
in activity scores between the groups at any time-point, indicating that changes in physical 
activity were not a factor in influencing overall results.  
 
Clinical indices 
The majority of the anthropometric and biochemical indices changed over 3-months; 
however, there were no significant differences between the groups for any of the measured 
clinical parameters over this time (Table 7). The average weight loss for the study sample was 
significant at 5.3 kg (p<0·001) (or 6.1% of baseline body weight) over the 3-month 
intervention. The mean weight changes ranged from a 2.1kg gain to a 14.7 kg loss, however 
weight loss was not significantly different between the groups (p=0·369). Waist 
measurements and percentage body fat decreased significantly compared to baseline 
  
   
(p<0.001). Regression analysis indicated that weight loss significantly predicted waist change 
(p<0·001) and percentage body fat (p<0·001). As expected, these predictions were strong (R
2 
0.389 and R
2
 0.615). Fasting blood glucose (p<0·001) and fasting insulin levels decreased 
over 3 months (p<0·001) but HbA1c did not change. No between groups differences were 
identified for any of these clinical indices (Table 7). The inflammatory cytokines IL1β, Il-6 
and Il-8, decreased significantly compared to baseline (p<0.001), as did TNFα (p<0·001). 
TAC levels also decreased significantly compared to baseline (p<0.001). There were no 
significant changes over time in hsCRP levels. The reduction in total cholesterol was not 
significantly different between the groups, with mean decreases of 0.3 (SD 0.6) mmol/l for 
the sorghum group and 0.5 (SD 0.7) mmol/l for the control. There was a significant decrease 
in total cholesterol over 3 months for all subjects (p<0.001), as well as significant decreases in 
HDL-c (p<0.001), LDL-c (p<0.05) and TAG (p<0.001) levels over this time.  
 
Subjective satiety 
VAS results were reviewed for the six daily time-points at 0, 6 and 12 weeks to compare any 
differences that may have existed between the control and test groups (RMANOVA). No 
significant differences were identified, demonstrating that all individuals reported similar 
feelings of hunger/fullness at the same test points (data not shown). 
 
DISCUSSION 
As a consequence of the dietary intervention, a reduction in energy intake was achieved in the 
overweight study sample. The reduced energy intake in both groups was an effective driver of 
weight loss over the 3-month period. Regardless of the diet subjects followed, they lost 
weight and experienced beneficial changes in waist circumference, fasting glucose, fasting 
insulin, lipids and inflammatory markers. If maintained over time, the mean weight loss of 
  
   
6.1% and reduced waist circumference (10.9 (SD 5.4) cm) for the study sample, could 
decrease risk of insulin resistance, impaired glucose tolerance and dyslipidemias [29], as well 
as lower the incidence of developing type 2 diabetes [30].  
 
The present study was not able to confirm differentiating effects of sorghum grain 
consumption on weight loss in an energy-restricted diet over 12 weeks where only the test 
foods were different. This design is necessary, however, for rigorous testing of individual 
foods where other dietary confounders are cancelled out.  Despite a previous acute satiety 
study with promising results [16], the present study showed that differences in meal satiety 
do not necessarily translate to weight reduction differences in the longer term. Bearing in 
mind that the energy restriction of the total diet was the same for both groups, subjects 
receiving foods made from sorghum included in the dietary advice, did not lose more weight 
than the subjects receiving control foods and similar overall dietary advice. Thus, the meal-
based satiety-enhancing mechanisms postulated to involve sorghum polyphenols did not have 
an enhancing effect on body weight changes over 3 months, nor on overall reduction in 
metabolic disease risk factors. Previous research conducted by our group has also shown that 
where both the control and intervention diets focus on healthy eating patterns and control for 
energy intakes, a difference in weight loss is not seen [31]. Ostensibly this is because weight 
loss is dependent on control of energy intake and we matched the percentage energy 
reduction in both arms. Typically also, no differences are seen when structured dietary advice 
to both the control and intervention groups is provided [32], as was the case in the present 
study. However, differences in other risk factor variables (affected by dietary attributes other 
than total energy, such as dietary fat [33, 34] have been observed. Given our assumption that 
a higher polyphenol intake from sorghum may have had similar effects, the study design was 
  
   
appropriate, but we may now need to look to other potential synergistic components of the 
diet, or a higher dose to pursue our hypothesis further.  
 
The lack of differences between groups in changes in lipid levels was not consistent with 
another study investigating the effects of consuming sorghum foods on serum lipid levels 
[35]. In this study, a significant reduction (p<0.05) in total cholesterol, TAG and HDL-c was 
observed in 10 males and 6 females after daily consumption of 100 g of unrefined sorghum in 
the form of pancakes over 3 weeks. However, this study used a small sample size (with low 
statistical power), reducing the likelihood that a statistically significant result reflects a true 
effect. Further, the content of subjects’ background diets was not adequately reported, making 
assessment of dietary confounders and final conclusions difficult. Overall, these results are 
ambiguous hence more human evidence for lipid effects in relation to sorghum consumption 
is warranted, and may be more relevant where weight loss inducing diets are not prescribed so 
as to discern lipid lowering effects independent of weight loss. 
 
A further strength of the present study was that we addressed the polyphenolic composition of 
the test foods. From a physiological perspective, we considered the results of a recent 
randomized, controlled, crossover human study, involving 22 healthy adults, assessing the 
acute effects of consuming pasta containing red or white wholegrain sorghum flour (30% 
sorghum, 70% semolina) on plasma total polyphenols, TAC and oxidative stress markers 
compared to a wheat control made from 100% semolina [36]. Pasta containing red wholegrain 
sorghum flour (RSP), but not white sorghum flour, enhanced antioxidant status and improved 
markers of oxidative stress in healthy subjects (p<0.001). The increase in plasma polyphenols 
by the RSP meal was attributed to its higher content of polyphenols. In the present study, 
despite significant differences in the levels of polyphenols and TAC between the test food 
  
   
products, we were not able to detect differences in the levels of inflammatory biomarkers and 
plasma TAC between the sorghum intervention and wheat control groups (Table 3). The 
reasons are not clear as to why the TAC levels unexpectedly decreased over time even though 
the inflammatory markers showed significant improvement. While standard protocols were 
followed and precautions taken, possible oxidation of blood samples during preparation or 
storage, cannot be ruled out [37].  Furthermore it may be that the effects of ingesting sorghum 
grain components are short-lived and subtle, hence the positive outcomes observed in acute 
studies may not translate to whole of diet studies conducted over a number of months. 
 
The lack of differences in subjective satiety scores was perhaps expected. VAS are validated 
for use in highly controlled situations [22], such as acute meal test studies. We justified the 
inclusion of VAS to enable a possible link between reported ratings in this study and those of 
our previous acute satiety study [16], though realistically, the small differences from month to 
month in the present study were unlikely to be captured accurately by the subjects using the 
VAS tool. An alternative appetite questionnaire, validated for use in free-living conditions 
[38], may have been more informative. 
 
Separating out the effects of individual components within a food, in this case the flaked 
cereal biscuit matrix, is difficult within a human intervention trial. To this end, a key strength 
of the present study is the comprehensive characterization of the physico-chemical properties 
of the test foods used in the intervention diets, assisting researchers to link clinical effects to 
components within the food. In our previous work [16], determination of polyphenolic 
compounds, dietary fiber, profiling of starch contents and proximate analyses of the RTE 
sorghum flaked biscuits, enabled us to hypothesize that the polyphenolic compounds played a 
role in observed acute satiety effects that would drive weight loss in the present RCT. Overall, 
  
   
the lack of positive results should not infer that sorghum is not a beneficial ingredient in 
cereal foods, as subjects consumed the foods successfully, lost weight, decreased their serum 
cholesterol and showed other positive outcomes related to metabolic health. The whole grain 
sorghum product was as effective as the whole grain wheat product in the present study. 
Sorghum, like other whole grain cereals, delivers beneficial, health-promoting components 
and properties (such as antioxidants, dietary fiber, SDS and valuable energy) when it is 
consumed as part of a healthy food within a healthy diet. 
 
As with most human dietary intervention trials, there are a number of confounding variables 
in the present study that require some consideration. Firstly, the trial was only a 3-month 
intervention and this period of time may not be long enough to detect differences between the 
subjects’ compliance with an energy restricted diet and the actual effects of the dietary 
intervention. It has been shown that subjects who reported greater compliance with a weight 
loss protocol lost more weight regardless of the dietary intervention [39], suggesting that 
strategies to increase adherence may be more important than the actual composition of the 
diet. Validated “measures of adherence” to enhance compliance to dietary advice in the 
context of clinical interventions would therefore be useful in future studies [40]. 
 
Secondly, the present study included similar test food products for both the intervention group 
and the control group, which only varied in the source of whole grain (sorghum versus 
wheat). The effect of individual grain components within the cereal biscuits, even if positive, 
are likely to be relatively small and hence showing a statistical difference between the groups 
would be difficult, especially over 3 months. Significant differences between the treatment 
and control groups may have been detected if the whole wheat control biscuits were lower in 
dietary fiber and higher in RDS compared to the sorghum biscuits. Further, instructing 
  
   
subjects to eat food products at both breakfast and at afternoon tea as part of the compliance 
criteria for the dietary intervention protocols, may have actually increased overall energy 
consumption at times when the subjects might otherwise have chosen not to eat or to eat less 
in either arm of the study.  
 
Thirdly, it is difficult to control the dietary intake of human subjects. Although food records 
and discussions with subjects during study interviews indicated high compliance with 
consumption of test products, the subjects were less compliant with the energy restriction as 
evidenced by the lower-than-predicted weight loss. All four subjects that withdrew from the 
study were from the intervention group, which could infer the greatest difficulty with 
compliance, but this is less likely given the reasons provided for their withdrawal. Lastly, 
large standard deviations existed within all the analyzed datasets, limiting the ability to detect 
significant results. The large standard deviations indicated that individual fluctuations are 
more varied than any overall effect of sorghum intake.  
 
CONCLUSION 
Although both groups experienced significant weight loss and general improvement in all 
clinical measures such as fasting glucose, insulin, cholesterol and key inflammatory 
biomarkers, no effects appeared specifically related to sorghum consumption. Overall, there 
were no discernable differences between an energy-restricted diet containing a wheat-based 
cereal food and that containing a sorghum-based cereal food.  With a longer intervention and 
greater exposure to the test foods, some differences might have been detected, as subtle 
effects of components in the cereal foods would become more prominent. Nevertheless, the 
consumption of sorghum flaked breakfast cereal biscuits in the context of an energy-restricted 
diet is not deleterious in overweight and mildly obese individuals, and in fact represents a 
  
   
viable gluten-free alternative to wheat in food products.  
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Table 1 - Dietary prescription (totaling 5, 500kJ) for a typical participant   
 
Food Group Portion or serve size  Number of serves / day 
Control or intervention products 1 flaked cereal biscuit = 15g 3 (2 biscuits at breakfast and 1 at afternoon tea) 
Breads/cereal/starchy vegetables 1 slice bread or 1/2 cup cooked pasta or 1/3 cup cooked rice or 1 small potato  4 
Other vegetables 1/2 cup cooked or 1 cup raw 2.5 cooked or 5 raw 
Fruit 1 piece fresh or 3/4 cup canned and drained 2 
Milk / alternatives 150ml light or 200ml skim, 100g low-fat yoghurt 2-3 
Meat / alternatives 30g meat or 50g fish or 20g low fat cheese  3-4 
Fats  1 tsp. oil or margarine or 1 tbsp. avocado 3-4 
 
  
  
   
Table 2 - Proximate and dietary fiber composition and energy content of flaked breakfast cereals, adapted from Stefoska-Needham et al. (2016) 
1,2
 
 
 
 
 
 
 
 
 
 
1Means (n=2) ± standard deviation 
2Values within a column with the same superscript letter denotes no significant difference (p>0.05) 
3Statistical comparison not possible as some replicates identical 
4Available carbohydrate calculated by difference 
  
Flaked breakfast cereal 
type 
Moisture 
(g/100g as is) 
Protein  
(g/100g as is) 
Fat  
(g/100g as is) 
Ash3 
(g/100g as is) 
Total dietary fiber 
(g/100g as is) 
Total available 
carbohydrates4  
(g/100g as is) 
Energy content 
(kJ/100g as is) 
Wheat control 6.6±0.0 13.7±0.2b 1.7±0.0a 1.6±0.0 9.6±0.1b 66.9±0.1a 1508±1a 
Sorghum (red) 6.6±0.0 9.4±0.1a 2.9±0.1b 1.6±0.0 7.7±0.0a 71.9±0.1b 1550±0b 
  
   
Table 3 - Free, bound and total phenolic content and antioxidant capacity of flaked breakfast cereals, adapted from Stefoska-Needham et al. (2016) 
1,2
 
Flaked breakfast cereal 
type 
Free PP 
(mg GAE/g as is) 
Bound PP 
(mg GAE/g as is) 
Total PP 
(mg GAE/g as is) 
Free AC 
(µmolTE/g as is) 
Bound AC 
(µmolTE/g as is) 
Total antioxidant capacity 
(µmolTE/g as is) 
Wheat control 0.71±0.01a 0.67±0.22a 1.37±0.21a 2.64±0.01a 2.67±0.01a 5.31±0.01a 
Sorghum (red) 1.27±0.01b 1.00±0.11a 2.27±0.12b 11.25±0.57b 9.16±0.62b 20.40±1.18b 
1Means (n=2) ± standard deviation 
2Values within a column with the same superscript letter denotes no significant difference (p>0.05) 
PP, polyphenolic; AC, antioxidant capacity; GAE, Gallic acid equivalents; TE, Trolox equivalents 
  
  
   
Table 4 - Starch properties of flaked breakfast cereals, adapted from Stefoska-Needham et al. (2016) 
1,2
 
Flaked breakfast 
cereal type 
Total starch3 
(g/100g as is) 
Rapidly digested starch 
(g/100g dry starch) 
Slowly digested starch 
(g/100g dry starch) 
Resistant starch 
(g/100g dry starch) 
Wheat control 54.2 ± 0.2a 31.9±1.6a 47.9±4.2a 20.2±3.9a 
Sorghum (red) 57.7 ± 2.3a 31.9±4.2a 46.9±7.7a 21.2±3.6a 
1Means (n=2) ± standard deviation 
2Values within a column with the same superscript letter denotes no significant difference (p>0.05) 
3Total starch was determined using a Megazyme K-TSTA 09/14 Total Starch Kit (Bray, Ireland) which excludes low molecular weight starch  
hydrolysis/breakdown products that may have resulted during the manufacturing process  
 
  
  
   
Table 5 - Baseline characteristics of study subjects (means and standard deviations) 
VARIABLE 
 CONTROL  SORGHUM  DIFFERENCE 
 
Mean SD 
 
Mean SD 
 p-value 
Age (years)  48.6 11.4  48.1 10.3  0.859 
Weight (kg)  86.1 9.8  87.1 12.9  0.732 
BMI (kg /m2)  31.6 2.8  31.2 3.5  0.632 
Waist (cm)  105.3 9.5  102.5 12.0  0.311 
Fat (%)  40.3 5.8  38.7 6.3  0.309 
Fasting Blood glucose (mmol/L)  5.2 0.4  5.3 0.6  0.297 
Fasting Insulin (mIU/L)  12.5 5.7  12.3 6.9  0.893 
HbA1c (%)  5.3 0.3  5.2 0.4  0.554 
Total Cholesterol (mmol/L)  5.6 1.0  5.3 1.0  0.173 
LDL-c (mmol/L)  3.5 0.9  3.2 0.8  0.193 
HDL-c (mmol/L)  1.4 0.4  1.5 0.3  0.533 
TAG (mmol/L)  1.6 0.8  1.3 0.7  0.155 
IL1 (pg/ml)  0.9 1.0  0.9 0.9  0.841 
Il-6 (pg/ml)  1.5 1.6  0.8 0.7  0.052 
Il-8 (pg/ml)  6.2 2.8  5.2 1.8  0.096 
TNFα (pg/ml)  2.9 1.3  3.2 1.2  0.483 
hsCRP (mg/L)  2.7 2.6  2.4 2.1  0.662 
TAC (mmol/L Trolox)  1.2 0.2  1.3 0.2  0.476 
Diastolic BP (mm Hg)  82.3 9.6  80.4 7.4  0.407 
Systolic BP (mm Hg)  126.2 16.9  122.3 14.4  0.349 
         
 
  
  
   
Table 6 - Energy and macronutrient intakes reported by subjects at baseline, mid-point and 3-months, with p-values for repeated measures ANOVA between 
control and sorghum groups (mean values and standard deviations) 
 
 
BASELINE  MID-POINT 3 MONTHS  P-VALUES 
 
CONTROL SORGHUM  CONTROL SORGHUM  CONTROL SORGHUM  
 
VARIABLE Mean SD Mean SD  Mean SD Mean SD  Mean SD Mean SD  Group Time Interaction 
Energy (kJ) 9274.0 2696.2 7897.3 2429.8  6993.0 2244.8 7363.9 2076.2  6752.8 2090.6 7082.0 1297.1  0.110 <0.001* 0.671 
Protein (g) 106.6 33.2 89.5 30.8  88.9 35.0 95.4 32.6  81.7 26.2 89.6 24.7  0.049* 0.008* 0.909 
% E Protein 20.0 5.2 19.5 4.1  22.4 6.5 21.9 4.0  20.7 3.4 21.5 4.1  0.56 0.059 
 
CHO (g) 234.6 84.5 190.6 60.7  187.8 74.4 181.4 43.5  177.9 56.8 183.2 40.9  0.144 0.040* 0.306 
% E CHO 39.9 5.1 39.1 7.09  42.6 8.3 40.0 5.2  42.6 6.3 41.5 6.0  0.811 0.161 
 
Total Fat (g) 85.1 25.7 77.2 31.5  54.9 23.5 61.9 26.0  57.1 23.8 57.6 15.3  <0.001* 0.381 0.979 
% E Total Fat 34.0 5.2 35.5 5.3  28.5 5.4 30.4 4.9  30.8 7.0 30.1 5.2  0.435 <0.001* 
 
SFA (g) 34.3 12.4 29.8 14.3  18.4 7.4 22.9 10.9  20.3 8.6 20.4 5.8  0.161 <0.001* 0.976 
% E SFA 13.7 3.2 13.6 3.3  9.7 2.0 11.3 2.8  11.0 3.0 10.7 2.2  0.090 <0.001* 
 
PUFA (g) 12.7 5.3 12.9 6.6  9.7 5.8 9.3 5.0  9.1 4.7 9.5 4.2  0.829 0.003* 0.946 
% E PUFA 5.1 1.7 6.1 2.8  4.9 2.0 4.5 1.5  4.9 1.9 4.9 1.6  0.234 0.081 
 
MUFA (g) 31.6 10.8 28.8 14.2  20.3 10.5 23.0 11.0  21.3 6.5 21.5 6.5  0.486 <0.001* 0.970 
% E MUFA 12.6 2.8 13.1 3.2  10.4 3.2 11.2 2.6  11.3 4.0 11.3 2.8  0.789 0.005* 
 
Total Fiber (g) 26.3 9.0 25.6 9.5  24.4 9.1 24.9 7.2  24.1 9.2 27.2 10.2  0.432 0.626 0.660 
E – energy; CHO – carbohydrate 
* Significant values (p<0.05) were measured using repeated measures ANOVA 
 
  
  
   
 
Table 7 - Changes in anthropometric and biochemical indices over time between control and sorghum groups (mean values and standard deviations) 
 
 
ALL GROUPS  CONTROL  SORGHUM  
P-VALUES 
CLINICAL Baseline data Mean change  Baseline data Mean change  Baseline data Mean change  
INDICES Mean  SD Mean  SD   Mean  SD Mean  SD  Mean  SD Mean SD   Group Time Interaction 
Weight (kg) 86.6  11.6 -5.3 3.7  86.1  9.8 -5.4 3.6  87.1  13.6 -5.2 4.0  0.369 <0.001* 0.772 
BMI (kg / m2) 31.3  3.1 -1.9 1.4  31.6  2.6 -1.9 1.3  31.1  3.4 -1.9 1.4  0.754 <0.001* 0.601 
Waist (cm) 104.2  10.9 -10.9 5.4  105.3  9.5 -11.8 5.6  102.9  12.5 -9.9 5.2  0.209 <0.001* 0.594 
Body fat (%) 39.4  6.0 -2.1 2.3  40.3  5.8 -2.1 2.3  38.3  6.9 -2.3 2.5  0.876 <0.001* 0.194 
Glucose (mmol/L) 5.26  0.50 -0.13 0.4  5.18  0.36 -0.11 0.3  5.35  0.62 -0.15 0.4  0.705 0.009* 0.162 
Insulin (mIU/L) 12.32  5.78 -2.86 3.3  12.55  5.8 -3.17 3.0  12.06  5.86 -2.53 3.7  0.481 0.000* 0.905 
HbA1c (mmol/L) 33.95  4.2 0.10 3.1  33.97  3.89 0.20 3.2  33.92  4.60 0.00 2.9  0.843 0.843 0.896 
HbA1c (%) 5.26  0.37 0.00 0.3  5.26  0.34 0.00 0.3  5.25  0.41 0.00 0.2  0.926 0.926 0.912 
Total cholesterol 
(mmol/L) 
5.47  0.99 -0.40 0.7 
 
5.64 0.98 -0.50 0.7 
 
5.28  0.99 -0.30 0.6 
 
0.139 <0.001* 0.384 
HDL-c (mmol/L) 1.42  0.38 -0.07 0.2  1.40  0.40 -0.10 0.2  1.45  0.37 -0.10 0.2  0.674 0.008* 0.454 
LDL-c (mmol/L) 3.39  0.85 -0.15 0.5  3.52  0.90 -0.20 0.6  3.24  0.79 -0.10 0.4  0.225 0.05 0.379 
TAG (mmol/L) 1.46  0.76 -0.40 0.6  1.59 0.81 -0.50 0.7  1.30  0.67 -0.30 0.5  0.393 <0.001* 0.174 
IL1β(pg/ml) 0.93  0.97 -0.15 0.4  0.92 1.03 -0.10 0.4  0.94  0.92 -0.20 0.3  0.565 0.004* 0.943 
Il-6 (pg/ml) 1.19  1.29 -0.22 0.3  1.48  1.59 -0.20 0.4  0.86  0.73 -0.20 0.3  0.752 <0.001* 0.071 
IL-8 (pg/ml) 5.73  2.46 -0.49 1.1  6.20  2.84 -0.40 1.2  5.19  1.86 -0.60 0.9  0.621 0.001* 0.075 
hsCRP (mg/L) 2.52  2.41 -0.28 1.8  2.65  2.64 -0.30 2.1  2.37  2.15 -0.20 1.3  0.059 0.207 0.728 
TNFα (pg/ml) 3.06  1.23 -0.76 0.8  2.95  1.27 -0.60 0.7  3.19  1.18 -0.90 0.8  0.110 <0.001* 0.748 
TAC (mmol/L 
Trolox) 
1.26  0.18 -0.06 0.1 
 
1.24  0.15 -0.10 0.1 
 
1.29  0.20 -0.10 0.1 
 
0.759 0.001* 0.247 
c – cholesterol; TAG –  triacylglycerides; HbA1c – glycosylated hemoglobin; IL1 – Interleukin 1; Il-6 – Interleukin 6; IL-8 – Interleukin 8; hsCRP – high sensitivity c-reactive protein; TNFα – tumour necrosis factor 
alpha; TAC – total antioxidant capacity 
* Significant values were measured using repeated measures ANOVA 
 
 
 
 
  
   
 
Fig. 1 Flow of participants through the trial 
 
